You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Bidders Circle Bayer's Animal Health Division


Industry Segment: Pharmaceutical & Biotech | Word Count: 659 Words

GALWAY, IRELAND--June 12, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The forthcoming sale of Bayer's animal medicines business is attracting the interest of leading European private equity firms in a battle that could see the division fetch up to 8 billion euro ($9 billion).

Within this article: Details bidder line up for Bayer animal division sale, leading products, estimated price, Bayer job cuts, related product line sales, Roundup cancer rulings and financial impact

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00